Content about Major

03.09.10

A single session of heat therapy using the Thermomed™ device appears to be as effective as a 10-day intravenous course of sodium stibogluconate (Pentostam) for the treatment of Leishmania major skin lesions, according to a new study by Naomi Aronson and her colleagues at the Uniformed Services University of the Health Sciences (USU) and Walter Reed Army Medical Center (WRAMC)...

02.20.10

Johns Hopkins Children's Center neurovirologist Robert Yolken, M.D., and collaborators from the Stanley Medical Research Institute have developed a large repository of brain and tissue samples to advance the understanding and treatment of bipolar disorder, major depression and schizophrenia.

12.31.09

Major League Baseball slugger Aaron Boone will be featured on January's episode of Sharing Miracles - a 30-minute public affairs television program that tells the compelling and inspirational stories of real patients. Sharing Miracles airs every week on more than 300 television stations nationwide.

12.04.09

Leading mental health researchers are warning that some of the most important health consequences of climate change will be on mental health, yet this issue is unlikely to be given much attention at the UN climate change conference in Copenhagen next week.

12.04.09

AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved once-daily SEROQUEL XR® (quetiapine fumarate) Extended Release Tablets as adjunctive (add-on) treatment to antidepressants in adults with Major Depressive Disorder (MDD).

11.19.09

A baby's sleep position is the best predictor of a misshapen skull condition known as deformational plagiocephaly - or the development of flat spots on an infant's head - according to findings reported by Arizona State University scientists in the December issue of the journal Pediatrics...

11.19.09

The artificial lower limbs of double-amputee Olympic hopeful Oscar Pistorius give him a clear and major advantage over his competition, taking 10 seconds or more off what his 400-meter race time would be if his prosthesis behaved like intact limbs. That's the conclusion - released to the public for the first time - of human performance experts Peter Weyand of Southern Methodist University in Dallas and Matthew Bundle of the University of Wyoming.

11.11.09
If humans are genetically related to chimps, why did our brains develop the innate ability for language and speech while theirs did not?    Scientists suspect that part of the answer to the mystery lies in a gene called FOXP2. When mutated, FOXP2 can disrupt speech and language in humans. Now, a UCLA–Emory University study reveals major differences between how the human and chimp versions of FOXP2 work, perhaps explaining why language is...

10.11.09

This month sees the start of an exciting and unique veterinary education project selected by the BVA Animal Welfare Foundation (BVA AWF) for funding under the Norman Hayward Fund. Maximising Value of Extra-Mural Study Placements on Cattle, Sheep and Horse Units aims to develop and validate welfare and health planning assessment tools for cattle, sheep and horses for students on their pre-clinical Extra Mural Study (EMS) placements.

07.01.09

While major advances have been made in the understanding of

06.29.09

In one of the most field-intensive efforts to explore the connection between malaria and tropical deforestation, a team led by Jonathan Patz, a specialist in the link between environment and health at the Nelson Institute for Environmental Studies at the University of Wisconsin-Madison, has established a strong correlation between the extent of forest destruction and the incidence of the Amazon's most dangerous malaria vector, the mosquito Anopheles darlingi.

06.24.09

Leaders of the major faith groups have put their support behind the Wall of Life, an interactive campaign launched today by NHS Blood and Transplant (NHSBT). The campaign - at http://www.walloflife.org.uk - aims to promote awareness of and support for organ donation to boost the number of people joining the NHS Organ Donor Register (ODR).

06.23.09

It is no coincidence that the stroke theme is being given wide exposure at the ENS Congress. Stroke has become a major challenge for health policy and for medicine in general. It is now the second most common cause of death globally and the major cause of adult disability in the industrialized countries. Pointing to WHO estimates, Prof. Ferro notes that "the incidence of stroke is expected to increase by another 30 percent by 2020.

06.15.09

This year the British Transplant Games takes place in Coventry and 900 transplant athletes are preparing to take part. For a handful of these athletes, the Games offers vital training and preparation for other major sporting challenges such as triathlons and marathons. The event organisers, Transplant Sport UK shines the spotlight on these inspiring people, who visibly demonstrate that there is life after transplant, allowing them to train to a high level of fitness against all the odds.

06.12.09

During circulation, arteries carry oxygen-rich blood from the heart to the limbs (and other parts of the body) and veins return oxygen-poor blood to the heart. Disease of the limb arteries is commonly referred to as PAD (peripheral arterial disease). Venous return from the lower limbs may be affected when major veins are obstructed (stenosis or occlusion) or when venous valves malfunction allowing abnormal reverse flow (reflux).

04.13.09

New research from Trinity College Dublin published in this month's Annals of Surgery points to a potentially significant advance in the treatment of patients undergoing major cancer surgery. The study was carried out by the oesophageal research group at Trinity College Dublin and St James's Hospital.

04.13.09

The U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee (PDAC) conducted a review of the safety and efficacy of supplemental new drug applications (sNDA) for Seroquel XR (quetiapine fumarate) extended-release tablets proposed for the treatment of major depressive disorder (MDD) and generalized anxiety disorder (GAD).

04.13.09

The U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee (PDAC) conducted a review of the safety and efficacy of supplemental new drug applications (sNDA) for Seroquel XR (quetiapine fumarate) extended-release tablets proposed for the treatment of major depressive disorder (MDD) and generalized anxiety disorder (GAD).

04.13.09

The U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee (PDAC) conducted a review of the safety and efficacy of supplemental new drug applications (sNDA) for Seroquel XR (quetiapine fumarate) extended-release tablets proposed for the treatment of major depressive disorder (MDD) and generalized anxiety disorder (GAD).